Spirochetal uveitis

International Ophthalmology Clinics

Volumn 46, Issue 2, 2006, Pages 123-139

  Hong, Jenny E ^a   Foster, Charles Stephen ^b  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b Massachusetts Eye Research and Surgery Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLINDAMYCIN; CORTICOSTEROID; DOXYCYCLINE; ERYTHROMYCIN; MYDRIATIC AGENT; OUTER SURFACE PROTEIN A; PENICILLIN G; STEROID; TETRACYCLINE; KI 67 ANTIGEN; RECOMBINANT EPIDERMAL GROWTH FACTOR;

AGGLUTINATION TEST; BORRELIA; CHEMOPROPHYLAXIS; CONFERENCE PAPER; CONGENITAL SYPHILIS; DISEASE COURSE; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE DISEASE; EYE PAIN; FLUORESCENT TREPONEMA ANTIBODY TEST; HERXHEIMER REACTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INCUBATION TIME; LEPTOSPIRA; LEPTOSPIROSIS; LYME DISEASE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAGIN TEST; SEROLOGY; SPIROCHETE INFECTION; SYPHILIS; TICK BITE; TREPONEMA; UVEITIS; VENEREAL DISEASE REACTION TEST; ZOONOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DRUG EFFICACY; EPITHELIZATION; HYDROCOLLOID DRESSING; KERATINOCYTE; SPLIT THICKNESS SKIN WOUND; SWINE; WOUND; WOUND HEALING;

EYE INFECTIONS, BACTERIAL; HUMANS; SPIROCHAETALES INFECTIONS; UVEITIS; ADMINISTRATION, TOPICAL; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; SKIN; SKIN DISEASES; SWINE; WOUND HEALING; WOUNDS AND INJURIES;

EID: 33746150706     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-4801.2006.00187.x     Document Type: Conference Paper

References (56)

1. Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol. 1996;114:593-599.
2. Canale-Parola E. Physiology and evolution of spirochetes. Bacteriol Rev. 1977;41:181-204.
3. Schmid GP. Epidemiology and clinical similarities of human spirochetal diseases. Rev Infect Dis. 1989;S1460-S1468.
4. Duke-Elder S, Perkins ES. Diseases of the uveal tract. In: Duke-Elder S, ed. System of Ophthalmology, vol IX. St. Louis: CV Mosby Company; 1966:292-325.
5. Rathinam SR. Ocular leptospirosis. Curr Opin Ophthalmol. 2002;13:381-386.
6. Ryan KJ. Spirochetes. In: Ryan KJ, Ray CG, eds. Sherris Medical Microbiology: An Introduction to Infectious Diseases. 4th ed. New York: McGraw-Hill; 2004:421-438.
7. Dana MR. Leptospirosis. In: Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. New York: W.B. Saunders Company; 2002;273-277.
8. Baer JC. Borreliosis. In: Foster CS, Vitale AT, eds. Diagnosis and, Treatment of Uveitis. New York: W.B. Saunders Company; 2002;245-259.
9. Steere AC. Lyme disease. N Engl J Med. 1989;321:586-596.
10. Steere AC. Lyme disease. N Engl J Med. 2001;345:115-125.
11. Burgdorfer W, Barbour AG, Hayes SF, et al. Lyme disease - a tick-borne spirochetosis? Science. 1982;216:1317-1319.
12. Zaidman GW. The ocular manifestations of Lyme disease. Int Ophthalmol Clin. 1997;37:13-28.
13. CDC. Lyme disease - United States, 2001-2002. MMWR. 2004;53:365-369.
14. Glifford SR. A review of the literature on the etiology of acute iritis. Am J Ophthalmol. 1931;14:100-110.
15. Woods AC. Modern concepts of the etiology of uveitis. Am J Ophthalmol. 1960;50:1170-1187.
16. Tamesis RR, Foster CS. Ocular syphilis. Ophthalmol. 1990;97:1281-1287.
17. Barile GR, Flynn TE. Syphilis exposure in patients with uveitis. Ophthalmology. 1997;104:1605-1609.
18. Department of Health and Human Resources. Sexually Transmitted Disease Surveillance, 1992. Atlanta Centers for Disease Control 1993;143-159.
19. Villanueva AV, Sahouri MJ, Ormerod LD, et al. Posterior uveitis in patients with positive serology for syphilis. Clin Infect Dis. 2000;30:479-485.
20. Aldave AJ, King JA, Cunningham ET Jr. Ocular syphilis. Curr Opin Ophthalmol. 2001;12:433-441.
21. CDC. Congenital syphilis - United States, 2002. MMWR. 2004;716-719.
22. Smith JL. Ocular Lyme borreliosis - 1991. Int Ophthalmol Clin. 1991;31:17-38.
23. Zhang JR, Norris SJ. Genetic variation of the Borrelia burgdorferi gene vlsE involves cassette-specific, segmental gene conversion. Infect Immun. 1998;66:3698-3704.
24. Hu LT, Klempner MS. Host-pathogen interactions in the immunopathogenesis of Lyme disease. J Clin Immunol. 1997;17:354-365.
25. Coleman JL, Gebbia JA, Piesman J, et al. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell. 1997;89:1111-1119.
26. Chu KM, Rathinam R, Namperumalsamy P, et al. Identification of Leptospira species in the pathogenesis of uveitis and determination of clinical ocular characteristics in South India. J Infect Dis. 1998;177:1314-1321.
27. Kalish RA, Leong JM, Steere AC. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and Osp B of Borrelia burgdorferi. Infect Immun. 1993;61:2774-2779.
28. Samson CM, Foster CS. Syphilis. In: Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. New York: W.B. Saunders Company; 2002:237-244.
29. Wilhelmus KR, Lukehart SA. Syphilis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. Boston: Mosby; 1996:1437-1466
30. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990;323:1438-1444.
31. Tierney DW. Ocular manifestations of syphilis. J Am Optom Assoc. 1989;60:463-466.
32. Rathinam SR, Namperumalsamy P. Leptospirosis. Ocular Immunol Inflam. 1999;7:109-118.
33. Rathinam SR, Namperumalsamy P, Cunningham ET Jr. Spontaneous cataract absorption in patients with leptospiral uveitis. Br J Ophthalmol. 2000;84:1135-1141.
34. Karma A, Seppala I, Mikkila H, et al. Diagnosis and clinical characteristics of ocular Lyme borreliosis. Am J Ophthalmol. 1995;119:127-135.
35. Clark JR, Carlson RD, Sasaki CT, et al. Facial paralysis in Lyme disease. Laryngoscope. 1985;95:1341-1345.
36. Lesser RL. Ocular manifestations of Lyme disease. Am J Med. 1995;98:605-625.
37. Rothermel H, Hedges TR III, Steere AC. Optic neuropathy in children with Lyme disease. Pediatrics. 2001;108:477-481.
38. Winward KE, Smith JL, Culbertson WW, et al. Ocular Lyme borreliosis. Am J Ophthalmol 1989;108:651-657.
39. Kauffmann DJ, Wormser GP. Ocular Lyme disease: case report and review of the literature. Br J Ophthalmol. 1990;74:325-327.
40. Mikkila HO, Seppala IJT, Viljanen MK, et al. The expanding clinical spectrum of ocular Lyme borreliosis. Ophthalmol. 2000;107:581-587.
41. Barkay S, Garzozi H. Leptospirosis and uveitis. Ann Ophthalmol. 1984;16:164-168.
42. Rathinam SR, Rathnam S, Selvaraj S, et al. Uveitis associated with an epidemic outbreak of leptospirosis. Am J Ophthalmol. 1997;124:71-79.
43. Steere AC, Duray PH, Kauffmann DJ, et al. Unilateral blindness caused by infection with the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med. 1985;103:382-384.
44. Wittpenn JR, Sibony PA, Dattwyler RJ. Lyme Borreliosis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. Boston: Mosby; 1996:1469-1479.
45. Ross WH, Sutton HFS. Acquired syphilitic uveitis. Arch Ophthalmol. 1980;98:496-498.
46. Merien F, Perolat P, Mancel E, et al. Detection of Leptospira DNA by polymerase chain reaction in aqueous humor of a patient with unilateral uveitis. J Infect Dis. 1993;168:1335-1336.
47. Winterkorn JMS. Lyme disease: neurologic and ophthalmic manifestations. Surv Ophthalmol. 1990;35:191-204.
48. Dressier F, Whalen JA, Reinhardt BN, et al. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis. 1993;167:392-400.
49. Suputtamongkol Y, Niwattayakul K, Suttinont C, et al. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis. 2004;39:1417-1424.
50. Murray CK, Ellis MW, Hospenthal DR. Susceptibility of Leptospira serovars to antimalarial agents. Am J Trop Med Hyg. 2004;71:685-686.
51. Dattwyler RJ, Halperin JJ, Volkman DJ, et al. Treatment of late Lyme borreliosis - randomised comparison of ceftriaxone and penicillin. Lancet. 1988;1:1191-1194.
52. Pfister HW, Preac-Mursic V, Wilske B, et al. Cefotaxime vs. penicillin G for acute neurologic manifestations of Lyme borreliosis: a prospective randomized study. Arch Neurol. 1989;46:1190-1194.
53. Burke JM, Schaberg DR. Neurosyphilis in the antibiotic era. Neurology. 1985;35:1368-1371.
54. Department of Health and Human Resources. Centers for Disease Control recommended treatment schedules - syphilis. MMWR. 1989;38:5-15.
55. Piesman J. Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks. J Infect Dis. 1993;167:1082-1085.
56. Shapiro ED, Gerber MA, Holabird NB, et al. A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med. 1992;327:1769-1773.